What distinguishes seed-competent from non-pathogenic tau in trans-synaptic transfer?
PARTIALLY ADDRESSED
The debate established trans-synaptic transfer as likely but didn't resolve what molecular features make some tau species capable of templating while others are not. This distinction is critical for designing interventions that block pathological spread without disrupting normal tau function.
Source: Debate session sess_SDA-2026-04-04-gap-tau-prop-20260402003221_20260412-085642 (Analysis: SDA-2026-04-04-gap-tau-prop-20260402003221)
Landscape Summary:
What distinguishes seed-competent from non-pathogenic tau in trans-synaptic transfer? is a 0.87 priority gap in neurodegeneration.
It has 0 linked hypotheses with average composite score 0.000.
Status: partially_addressed.
Key Unanswered Questions
What is the optimal TREM2 modulation strategy across disease stages?
How does DAM activation state affect therapeutic outcomes?
What biomarkers predict response to TREM2-targeted interventions?
Key Researchers
Colonna, Sevlever, et al. (TREM2 biology)
Clinical Trials
What distinguishes seed-competent from non-pathogenic tau in trans-synaptic transfer? — INVOKE-2 (completed)
📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
60%
Resolution
0
Mechanistic Families
Gap Resolution Progress60%
Hypothesis Score Distribution
🏆 Competing Hypotheses (Ranked by Score)
No hypotheses linked to this gap yet.
🌊 Knowledge Graph Connections
No knowledge graph edges recorded
🕑 Activity Feed
✏update on knowledge_gapby None2026-04-26T15:23
✏update on knowledge_gapby None2026-04-26T15:23
✏update on knowledge_gapby None2026-04-26T15:23
✏update on knowledge_gapby None2026-04-26T15:23
✏update on knowledge_gapby None2026-04-26T15:23
💬 Discussion
No discussions yet. Be the first to comment.
📋 Investigation Sub-Tasks
Create sub-tasks to investigate specific aspects of this gap:
Find more evidence for top-scoring hypotheses
Run multi-agent debate on unresolved sub-questions